1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Bio Similars/Subsequent Entry Biologic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Monoclonal Antibodies
        1.2.3 Interferon
        1.2.4 Erythropoietin
        1.2.5 Insulin
        1.2.6 Vaccines
        1.2.7 Other
    1.3 Market by Application
        1.3.1 Global Bio Similars/Subsequent Entry Biologic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Tumor
        1.3.3 Diabetes
        1.3.4 Cardiovascular
        1.3.5 Hemophilia
        1.3.6 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Bio Similars/Subsequent Entry Biologic Market Perspective (2017-2028)
    2.2 Bio Similars/Subsequent Entry Biologic Growth Trends by Region
        2.2.1 Bio Similars/Subsequent Entry Biologic Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Bio Similars/Subsequent Entry Biologic Historic Market Size by Region (2017-2022)
        2.2.3 Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Region (2023-2028)
    2.3 Bio Similars/Subsequent Entry Biologic Market Dynamics
        2.3.1 Bio Similars/Subsequent Entry Biologic Industry Trends
        2.3.2 Bio Similars/Subsequent Entry Biologic Market Drivers
        2.3.3 Bio Similars/Subsequent Entry Biologic Market Challenges
        2.3.4 Bio Similars/Subsequent Entry Biologic Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Bio Similars/Subsequent Entry Biologic Players by Revenue
        3.1.1 Global Top Bio Similars/Subsequent Entry Biologic Players by Revenue (2017-2022)
        3.1.2 Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Players (2017-2022)
    3.2 Global Bio Similars/Subsequent Entry Biologic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Bio Similars/Subsequent Entry Biologic Revenue
    3.4 Global Bio Similars/Subsequent Entry Biologic Market Concentration Ratio
        3.4.1 Global Bio Similars/Subsequent Entry Biologic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Bio Similars/Subsequent Entry Biologic Revenue in 2021
    3.5 Bio Similars/Subsequent Entry Biologic Key Players Head office and Area Served
    3.6 Key Players Bio Similars/Subsequent Entry Biologic Product Solution and Service
    3.7 Date of Enter into Bio Similars/Subsequent Entry Biologic Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Bio Similars/Subsequent Entry Biologic Breakdown Data by Type
    4.1 Global Bio Similars/Subsequent Entry Biologic Historic Market Size by Type (2017-2022)
    4.2 Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Type (2023-2028)
5 Bio Similars/Subsequent Entry Biologic Breakdown Data by Application
    5.1 Global Bio Similars/Subsequent Entry Biologic Historic Market Size by Application (2017-2022)
    5.2 Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Bio Similars/Subsequent Entry Biologic Market Size (2017-2028)
    6.2 North America Bio Similars/Subsequent Entry Biologic Market Size by Type
        6.2.1 North America Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
        6.2.2 North America Bio Similars/Subsequent Entry Biologic Market Size by Type (2023-2028)
        6.2.3 North America Bio Similars/Subsequent Entry Biologic Market Share by Type (2017-2028)
    6.3 North America Bio Similars/Subsequent Entry Biologic Market Size by Application
        6.3.1 North America Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
        6.3.2 North America Bio Similars/Subsequent Entry Biologic Market Size by Application (2023-2028)
        6.3.3 North America Bio Similars/Subsequent Entry Biologic Market Share by Application (2017-2028)
    6.4 North America Bio Similars/Subsequent Entry Biologic Market Size by Country
        6.4.1 North America Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022)
        6.4.2 North America Bio Similars/Subsequent Entry Biologic Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Bio Similars/Subsequent Entry Biologic Market Size (2017-2028)
    7.2 Europe Bio Similars/Subsequent Entry Biologic Market Size by Type
        7.2.1 Europe Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
        7.2.2 Europe Bio Similars/Subsequent Entry Biologic Market Size by Type (2023-2028)
        7.2.3 Europe Bio Similars/Subsequent Entry Biologic Market Share by Type (2017-2028)
    7.3 Europe Bio Similars/Subsequent Entry Biologic Market Size by Application
        7.3.1 Europe Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
        7.3.2 Europe Bio Similars/Subsequent Entry Biologic Market Size by Application (2023-2028)
        7.3.3 Europe Bio Similars/Subsequent Entry Biologic Market Share by Application (2017-2028)
    7.4 Europe Bio Similars/Subsequent Entry Biologic Market Size by Country
        7.4.1 Europe Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022)
        7.4.2 Europe Bio Similars/Subsequent Entry Biologic Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size (2017-2028)
    8.2 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Type
        8.2.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Share by Type (2017-2028)
    8.3 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Application
        8.3.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Share by Application (2017-2028)
    8.4 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Region
        8.4.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Bio Similars/Subsequent Entry Biologic Market Size (2017-2028)
    9.2 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Type
        9.2.1 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
        9.2.2 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Type (2023-2028)
        9.2.3 Latin America Bio Similars/Subsequent Entry Biologic Market Share by Type (2017-2028)
    9.3 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Application
        9.3.1 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
        9.3.2 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Application (2023-2028)
        9.3.3 Latin America Bio Similars/Subsequent Entry Biologic Market Share by Application (2017-2028)
    9.4 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Country
        9.4.1 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022)
        9.4.2 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size (2017-2028)
    10.2 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Type
        10.2.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Share by Type (2017-2028)
    10.3 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Application
        10.3.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Share by Application (2017-2028)
    10.4 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Country
        10.4.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Sun Pharma
        11.1.1 Sun Pharma Company Details
        11.1.2 Sun Pharma Business Overview
        11.1.3 Sun Pharma Bio Similars/Subsequent Entry Biologic Introduction
        11.1.4 Sun Pharma Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.1.5 Sun Pharma Recent Developments
    11.2 Synthon Pharmaceuticals
        11.2.1 Synthon Pharmaceuticals Company Details
        11.2.2 Synthon Pharmaceuticals Business Overview
        11.2.3 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Introduction
        11.2.4 Synthon Pharmaceuticals Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.2.5 Synthon Pharmaceuticals Recent Developments
    11.3 Teva Pharmaceutical Industries
        11.3.1 Teva Pharmaceutical Industries Company Details
        11.3.2 Teva Pharmaceutical Industries Business Overview
        11.3.3 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Introduction
        11.3.4 Teva Pharmaceutical Industries Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.3.5 Teva Pharmaceutical Industries Recent Developments
    11.4 LG Life Sciences
        11.4.1 LG Life Sciences Company Details
        11.4.2 LG Life Sciences Business Overview
        11.4.3 LG Life Sciences Bio Similars/Subsequent Entry Biologic Introduction
        11.4.4 LG Life Sciences Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.4.5 LG Life Sciences Recent Developments
    11.5 Celltrion Biocon
        11.5.1 Celltrion Biocon Company Details
        11.5.2 Celltrion Biocon Business Overview
        11.5.3 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Introduction
        11.5.4 Celltrion Biocon Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.5.5 Celltrion Biocon Recent Developments
    11.6 Hospira
        11.6.1 Hospira Company Details
        11.6.2 Hospira Business Overview
        11.6.3 Hospira Bio Similars/Subsequent Entry Biologic Introduction
        11.6.4 Hospira Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.6.5 Hospira Recent Developments
    11.7 Merck
        11.7.1 Merck Company Details
        11.7.2 Merck Business Overview
        11.7.3 Merck Bio Similars/Subsequent Entry Biologic Introduction
        11.7.4 Merck Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.7.5 Merck Recent Developments
    11.8 Biogen idec
        11.8.1 Biogen idec Company Details
        11.8.2 Biogen idec Business Overview
        11.8.3 Biogen idec Bio Similars/Subsequent Entry Biologic Introduction
        11.8.4 Biogen idec Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.8.5 Biogen idec Recent Developments
    11.9 Genentech (Roche)
        11.9.1 Genentech (Roche) Company Details
        11.9.2 Genentech (Roche) Business Overview
        11.9.3 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Introduction
        11.9.4 Genentech (Roche) Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.9.5 Genentech (Roche) Recent Developments
    11.10 Pfizer
        11.10.1 Pfizer Company Details
        11.10.2 Pfizer Business Overview
        11.10.3 Pfizer Bio Similars/Subsequent Entry Biologic Introduction
        11.10.4 Pfizer Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.10.5 Pfizer Recent Developments
    11.11 Celltrion
        11.11.1 Celltrion Company Details
        11.11.2 Celltrion Business Overview
        11.11.3 Celltrion Bio Similars/Subsequent Entry Biologic Introduction
        11.11.4 Celltrion Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.11.5 Celltrion Recent Developments
    11.12 Biocon
        11.12.1 Biocon Company Details
        11.12.2 Biocon Business Overview
        11.12.3 Biocon Bio Similars/Subsequent Entry Biologic Introduction
        11.12.4 Biocon Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.12.5 Biocon Recent Developments
    11.13 Amgen
        11.13.1 Amgen Company Details
        11.13.2 Amgen Business Overview
        11.13.3 Amgen Bio Similars/Subsequent Entry Biologic Introduction
        11.13.4 Amgen Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.13.5 Amgen Recent Developments
    11.14 Samsung Biologics
        11.14.1 Samsung Biologics Company Details
        11.14.2 Samsung Biologics Business Overview
        11.14.3 Samsung Biologics Bio Similars/Subsequent Entry Biologic Introduction
        11.14.4 Samsung Biologics Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.14.5 Samsung Biologics Recent Developments
    11.15 Mylan
        11.15.1 Mylan Company Details
        11.15.2 Mylan Business Overview
        11.15.3 Mylan Bio Similars/Subsequent Entry Biologic Introduction
        11.15.4 Mylan Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.15.5 Mylan Recent Developments
    11.16 Dr. Reddy's Laboratories
        11.16.1 Dr. Reddy's Laboratories Company Details
        11.16.2 Dr. Reddy's Laboratories Business Overview
        11.16.3 Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Introduction
        11.16.4 Dr. Reddy's Laboratories Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.16.5 Dr. Reddy's Laboratories Recent Developments
    11.17 Stada Arzneimittel AG
        11.17.1 Stada Arzneimittel AG Company Details
        11.17.2 Stada Arzneimittel AG Business Overview
        11.17.3 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Introduction
        11.17.4 Stada Arzneimittel AG Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.17.5 Stada Arzneimittel AG Recent Developments
    11.18 AbbVie
        11.18.1 AbbVie Company Details
        11.18.2 AbbVie Business Overview
        11.18.3 AbbVie Bio Similars/Subsequent Entry Biologic Introduction
        11.18.4 AbbVie Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.18.5 AbbVie Recent Developments
    11.19 Sanofi-Aventis
        11.19.1 Sanofi-Aventis Company Details
        11.19.2 Sanofi-Aventis Business Overview
        11.19.3 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Introduction
        11.19.4 Sanofi-Aventis Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.19.5 Sanofi-Aventis Recent Developments
    11.20 Johnson & Johnson
        11.20.1 Johnson & Johnson Company Details
        11.20.2 Johnson & Johnson Business Overview
        11.20.3 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Introduction
        11.20.4 Johnson & Johnson Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.20.5 Johnson & Johnson Recent Developments
    11.21 Novo Nordisk
        11.21.1 Novo Nordisk Company Details
        11.21.2 Novo Nordisk Business Overview
        11.21.3 Novo Nordisk Bio Similars/Subsequent Entry Biologic Introduction
        11.21.4 Novo Nordisk Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.21.5 Novo Nordisk Recent Developments
    11.22 Eli Lilly
        11.22.1 Eli Lilly Company Details
        11.22.2 Eli Lilly Business Overview
        11.22.3 Eli Lilly Bio Similars/Subsequent Entry Biologic Introduction
        11.22.4 Eli Lilly Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.22.5 Eli Lilly Recent Developments
    11.23 Novartis
        11.23.1 Novartis Company Details
        11.23.2 Novartis Business Overview
        11.23.3 Novartis Bio Similars/Subsequent Entry Biologic Introduction
        11.23.4 Novartis Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.23.5 Novartis Recent Developments
    11.24 3sbio
        11.24.1 3sbio Company Details
        11.24.2 3sbio Business Overview
        11.24.3 3sbio Bio Similars/Subsequent Entry Biologic Introduction
        11.24.4 3sbio Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.24.5 3sbio Recent Developments
    11.25 Biotech
        11.25.1 Biotech Company Details
        11.25.2 Biotech Business Overview
        11.25.3 Biotech Bio Similars/Subsequent Entry Biologic Introduction
        11.25.4 Biotech Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.25.5 Biotech Recent Developments
    11.26 Gelgen
        11.26.1 Gelgen Company Details
        11.26.2 Gelgen Business Overview
        11.26.3 Gelgen Bio Similars/Subsequent Entry Biologic Introduction
        11.26.4 Gelgen Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.26.5 Gelgen Recent Developments
    11.27 Innovent
        11.27.1 Innovent Company Details
        11.27.2 Innovent Business Overview
        11.27.3 Innovent Bio Similars/Subsequent Entry Biologic Introduction
        11.27.4 Innovent Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.27.5 Innovent Recent Developments
    11.28 Dong Bao
        11.28.1 Dong Bao Company Details
        11.28.2 Dong Bao Business Overview
        11.28.3 Dong Bao Bio Similars/Subsequent Entry Biologic Introduction
        11.28.4 Dong Bao Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.28.5 Dong Bao Recent Developments
    11.29 Ganlee
        11.29.1 Ganlee Company Details
        11.29.2 Ganlee Business Overview
        11.29.3 Ganlee Bio Similars/Subsequent Entry Biologic Introduction
        11.29.4 Ganlee Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
        11.29.5 Ganlee Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Bio Similars/Subsequent Entry Biologic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Monoclonal Antibodies
    Table 3. Key Players of Interferon
    Table 4. Key Players of Erythropoietin
    Table 5. Key Players of Insulin
    Table 6. Key Players of Vaccines
    Table 7. Key Players of Other
    Table 8. Global Bio Similars/Subsequent Entry Biologic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 9. Global Bio Similars/Subsequent Entry Biologic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Bio Similars/Subsequent Entry Biologic Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Bio Similars/Subsequent Entry Biologic Market Share by Region (2017-2022)
    Table 12. Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Bio Similars/Subsequent Entry Biologic Market Share by Region (2023-2028)
    Table 14. Bio Similars/Subsequent Entry Biologic Market Trends
    Table 15. Bio Similars/Subsequent Entry Biologic Market Drivers
    Table 16. Bio Similars/Subsequent Entry Biologic Market Challenges
    Table 17. Bio Similars/Subsequent Entry Biologic Market Restraints
    Table 18. Global Bio Similars/Subsequent Entry Biologic Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Bio Similars/Subsequent Entry Biologic Revenue Share by Players (2017-2022)
    Table 20. Global Top Bio Similars/Subsequent Entry Biologic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio Similars/Subsequent Entry Biologic as of 2021)
    Table 21. Ranking of Global Top Bio Similars/Subsequent Entry Biologic Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Bio Similars/Subsequent Entry Biologic Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Bio Similars/Subsequent Entry Biologic Product Solution and Service
    Table 25. Date of Enter into Bio Similars/Subsequent Entry Biologic Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Type (2017-2022)
    Table 29. Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Type (2023-2028)
    Table 31. Global Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Bio Similars/Subsequent Entry Biologic Revenue Share by Application (2017-2022)
    Table 33. Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Bio Similars/Subsequent Entry Biologic Revenue Share by Application (2023-2028)
    Table 35. North America Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & (US$ Million)
    Table 36. North America Bio Similars/Subsequent Entry Biologic Market Size by Type (2023-2028) & (US$ Million)
    Table 37. North America Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & (US$ Million)
    Table 38. North America Bio Similars/Subsequent Entry Biologic Market Size by Application (2023-2028) & (US$ Million)
    Table 39. North America Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022) & (US$ Million)
    Table 40. North America Bio Similars/Subsequent Entry Biologic Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Europe Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & (US$ Million)
    Table 42. Europe Bio Similars/Subsequent Entry Biologic Market Size by Type (2023-2028) & (US$ Million)
    Table 43. Europe Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & (US$ Million)
    Table 44. Europe Bio Similars/Subsequent Entry Biologic Market Size by Application (2023-2028) & (US$ Million)
    Table 45. Europe Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022) & (US$ Million)
    Table 46. Europe Bio Similars/Subsequent Entry Biologic Market Size by Country (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Bio Similars/Subsequent Entry Biologic Market Size by Type (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Bio Similars/Subsequent Entry Biologic Market Size by Application (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Bio Similars/Subsequent Entry Biologic Market Size by Region (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Bio Similars/Subsequent Entry Biologic Market Size by Region (2023-2028) & (US$ Million)
    Table 53. Latin America Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & (US$ Million)
    Table 54. Latin America Bio Similars/Subsequent Entry Biologic Market Size by Type (2023-2028) & (US$ Million)
    Table 55. Latin America Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & (US$ Million)
    Table 56. Latin America Bio Similars/Subsequent Entry Biologic Market Size by Application (2023-2028) & (US$ Million)
    Table 57. Latin America Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022) & (US$ Million)
    Table 58. Latin America Bio Similars/Subsequent Entry Biologic Market Size by Country (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Bio Similars/Subsequent Entry Biologic Market Size by Type (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Bio Similars/Subsequent Entry Biologic Market Size by Application (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Bio Similars/Subsequent Entry Biologic Market Size by Country (2023-2028) & (US$ Million)
    Table 65. Sun Pharma Company Details
    Table 66. Sun Pharma Business Overview
    Table 67. Sun Pharma Bio Similars/Subsequent Entry Biologic Product
    Table 68. Sun Pharma Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 69. Sun Pharma Recent Developments
    Table 70. Synthon Pharmaceuticals Company Details
    Table 71. Synthon Pharmaceuticals Business Overview
    Table 72. Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Product
    Table 73. Synthon Pharmaceuticals Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 74. Synthon Pharmaceuticals Recent Developments
    Table 75. Teva Pharmaceutical Industries Company Details
    Table 76. Teva Pharmaceutical Industries Business Overview
    Table 77. Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Product
    Table 78. Teva Pharmaceutical Industries Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 79. Teva Pharmaceutical Industries Recent Developments
    Table 80. LG Life Sciences Company Details
    Table 81. LG Life Sciences Business Overview
    Table 82. LG Life Sciences Bio Similars/Subsequent Entry Biologic Product
    Table 83. LG Life Sciences Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 84. LG Life Sciences Recent Developments
    Table 85. Celltrion Biocon Company Details
    Table 86. Celltrion Biocon Business Overview
    Table 87. Celltrion Biocon Bio Similars/Subsequent Entry Biologic Product
    Table 88. Celltrion Biocon Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 89. Celltrion Biocon Recent Developments
    Table 90. Hospira Company Details
    Table 91. Hospira Business Overview
    Table 92. Hospira Bio Similars/Subsequent Entry Biologic Product
    Table 93. Hospira Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 94. Hospira Recent Developments
    Table 95. Merck Company Details
    Table 96. Merck Business Overview
    Table 97. Merck Bio Similars/Subsequent Entry Biologic Product
    Table 98. Merck Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 99. Merck Recent Developments
    Table 100. Biogen idec Company Details
    Table 101. Biogen idec Business Overview
    Table 102. Biogen idec Bio Similars/Subsequent Entry Biologic Product
    Table 103. Biogen idec Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 104. Biogen idec Recent Developments
    Table 105. Genentech (Roche) Company Details
    Table 106. Genentech (Roche) Business Overview
    Table 107. Genentech (Roche) Bio Similars/Subsequent Entry Biologic Product
    Table 108. Genentech (Roche) Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 109. Genentech (Roche) Recent Developments
    Table 110. Pfizer Company Details
    Table 111. Pfizer Business Overview
    Table 112. Pfizer Bio Similars/Subsequent Entry Biologic Product
    Table 113. Pfizer Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 114. Pfizer Recent Developments
    Table 115. Celltrion Company Details
    Table 116. Celltrion Business Overview
    Table 117. Celltrion Bio Similars/Subsequent Entry Biologic Product
    Table 118. Celltrion Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 119. Celltrion Recent Developments
    Table 120. Biocon Company Details
    Table 121. Biocon Business Overview
    Table 122. Biocon Bio Similars/Subsequent Entry Biologic Product
    Table 123. Biocon Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 124. Biocon Recent Developments
    Table 125. Amgen Company Details
    Table 126. Amgen Business Overview
    Table 127. Amgen Bio Similars/Subsequent Entry Biologic Product
    Table 128. Amgen Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 129. Amgen Recent Developments
    Table 130. Samsung Biologics Company Details
    Table 131. Samsung Biologics Business Overview
    Table 132. Samsung Biologics Bio Similars/Subsequent Entry Biologic Product
    Table 133. Samsung Biologics Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 134. Samsung Biologics Recent Developments
    Table 135. Mylan Company Details
    Table 136. Mylan Business Overview
    Table 137. Mylan Bio Similars/Subsequent Entry Biologic Product
    Table 138. Mylan Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 139. Mylan Recent Developments
    Table 140. Dr. Reddy's Laboratories Company Details
    Table 141. Dr. Reddy's Laboratories Business Overview
    Table 142. Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Product
    Table 143. Dr. Reddy's Laboratories Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 144. Dr. Reddy's Laboratories Recent Developments
    Table 145. Stada Arzneimittel AG Company Details
    Table 146. Stada Arzneimittel AG Business Overview
    Table 147. Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Product
    Table 148. Stada Arzneimittel AG Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 149. Stada Arzneimittel AG Recent Developments
    Table 150. AbbVie Company Details
    Table 151. AbbVie Business Overview
    Table 152. AbbVie Bio Similars/Subsequent Entry Biologic Product
    Table 153. AbbVie Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 154. AbbVie Recent Developments
    Table 155. Sanofi-Aventis Company Details
    Table 156. Sanofi-Aventis Business Overview
    Table 157. Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Product
    Table 158. Sanofi-Aventis Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 159. Sanofi-Aventis Recent Developments
    Table 160. Johnson & Johnson Company Details
    Table 161. Johnson & Johnson Business Overview
    Table 162. Johnson & Johnson Bio Similars/Subsequent Entry Biologic Product
    Table 163. Johnson & Johnson Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 164. Johnson & Johnson Recent Developments
    Table 165. Novo Nordisk Company Details
    Table 166. Novo Nordisk Business Overview
    Table 167. Novo Nordisk Bio Similars/Subsequent Entry Biologic Product
    Table 168. Novo Nordisk Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 169. Novo Nordisk Recent Developments
    Table 170. Eli Lilly Company Details
    Table 171. Eli Lilly Business Overview
    Table 172. Eli Lilly Bio Similars/Subsequent Entry Biologic Product
    Table 173. Eli Lilly Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 174. Eli Lilly Recent Developments
    Table 175. Novartis Company Details
    Table 176. Novartis Business Overview
    Table 177. Novartis Bio Similars/Subsequent Entry Biologic Product
    Table 178. Novartis Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 179. Novartis Recent Developments
    Table 180. 3sbio Company Details
    Table 181. 3sbio Business Overview
    Table 182. 3sbio Bio Similars/Subsequent Entry Biologic Product
    Table 183. 3sbio Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 184. 3sbio Recent Developments
    Table 185. Biotech Company Details
    Table 186. Biotech Business Overview
    Table 187. Biotech Bio Similars/Subsequent Entry Biologic Product
    Table 188. Biotech Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 189. Biotech Recent Developments
    Table 190. Gelgen Company Details
    Table 191. Gelgen Business Overview
    Table 192. Gelgen Bio Similars/Subsequent Entry Biologic Product
    Table 193. Gelgen Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 194. Gelgen Recent Developments
    Table 195. Innovent Company Details
    Table 196. Innovent Business Overview
    Table 197. Innovent Bio Similars/Subsequent Entry Biologic Product
    Table 198. Innovent Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 199. Innovent Recent Developments
    Table 200. Dong Bao Company Details
    Table 201. Dong Bao Business Overview
    Table 202. Dong Bao Bio Similars/Subsequent Entry Biologic Product
    Table 203. Dong Bao Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 204. Dong Bao Recent Developments
    Table 205. Ganlee Company Details
    Table 206. Ganlee Business Overview
    Table 207. Ganlee Bio Similars/Subsequent Entry Biologic Product
    Table 208. Ganlee Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
    Table 209. Ganlee Recent Developments
    Table 210. Research Programs/Design for This Report
    Table 211. Key Data Information from Secondary Sources
    Table 212. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Bio Similars/Subsequent Entry Biologic Market Share by Type: 2021 VS 2028
    Figure 2. Monoclonal Antibodies Features
    Figure 3. Interferon Features
    Figure 4. Erythropoietin Features
    Figure 5. Insulin Features
    Figure 6. Vaccines Features
    Figure 7. Other Features
    Figure 8. Global Bio Similars/Subsequent Entry Biologic Market Share by Application: 2021 VS 2028
    Figure 9. Tumor Case Studies
    Figure 10. Diabetes Case Studies
    Figure 11. Cardiovascular Case Studies
    Figure 12. Hemophilia Case Studies
    Figure 13. Other Case Studies
    Figure 14. Bio Similars/Subsequent Entry Biologic Report Years Considered
    Figure 15. Global Bio Similars/Subsequent Entry Biologic Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global Bio Similars/Subsequent Entry Biologic Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Bio Similars/Subsequent Entry Biologic Market Share by Region: 2021 VS 2028
    Figure 18. Global Bio Similars/Subsequent Entry Biologic Market Share by Players in 2021
    Figure 19. Global Top Bio Similars/Subsequent Entry Biologic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio Similars/Subsequent Entry Biologic as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by Bio Similars/Subsequent Entry Biologic Revenue in 2021
    Figure 21. North America Bio Similars/Subsequent Entry Biologic Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. North America Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2028)
    Figure 23. North America Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2028)
    Figure 24. North America Bio Similars/Subsequent Entry Biologic Market Size Share by Country (2017-2028)
    Figure 25. United States Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Canada Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Europe Bio Similars/Subsequent Entry Biologic Market Size YoY (2017-2028) & (US$ Million)
    Figure 28. Europe Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2028)
    Figure 29. Europe Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2028)
    Figure 30. Europe Bio Similars/Subsequent Entry Biologic Market Size Share by Country (2017-2028)
    Figure 31. Germany Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. France Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. U.K. Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Italy Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Russia Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Nordic Countries Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size YoY (2017-2028) & (US$ Million)
    Figure 38. Asia Pacific Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2028)
    Figure 39. Asia Pacific Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2028)
    Figure 40. Asia Pacific Bio Similars/Subsequent Entry Biologic Market Size Share by Region (2017-2028)
    Figure 41. China Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Japan Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. South Korea Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Southeast Asia Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. India Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Australia Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 47. Latin America Bio Similars/Subsequent Entry Biologic Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Latin America Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2028)
    Figure 49. Latin America Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2028)
    Figure 50. Latin America Bio Similars/Subsequent Entry Biologic Market Size Share by Country (2017-2028)
    Figure 51. Mexico Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Brazil Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size YoY (2017-2028) & (US$ Million)
    Figure 54. Middle East and Africa Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2028)
    Figure 55. Middle East and Africa Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2028)
    Figure 56. Middle East and Africa Bio Similars/Subsequent Entry Biologic Market Size Share by Country (2017-2028)
    Figure 57. Turkey Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Saudi Arabia Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. UAE Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 60. Sun Pharma Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 61. Synthon Pharmaceuticals Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 62. Teva Pharmaceutical Industries Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 63. LG Life Sciences Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 64. Celltrion Biocon Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 65. Hospira Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 66. Merck Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 67. Biogen idec Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 68. Genentech (Roche) Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 69. Pfizer Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 70. Celltrion Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 71. Biocon Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 72. Amgen Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 73. Samsung Biologics Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 74. Mylan Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 75. Dr. Reddy's Laboratories Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 76. Stada Arzneimittel AG Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 77. AbbVie Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 78. Sanofi-Aventis Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 79. Johnson & Johnson Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 80. Novo Nordisk Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 81. Eli Lilly Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 82. Novartis Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 83. 3sbio Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 84. Biotech Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 85. Gelgen Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 86. Innovent Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 87. Dong Bao Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 88. Ganlee Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022)
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed